1. Gans HA, et al. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months Journal of the American Medical Association 1998; 280: 527–532.
2. Redd SC, et al. Comparison of vaccination with measles-mumps rubella vaccine at 9, 12 and 15 months of age. Journal of Infectious Diseases 2004; 189: S116–122.
3. Halsey NA, et al. Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illness. New England Journal of Medicine 1985; 313: 544–549.
4. Ceyhan M, et al. Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months as compared to monovalent measles vaccination of children at nine months followed by MMR revaccination at fifteen months of age. Vaccine 2001; 19: 4473–4478.
5. Marks JS, Halpin TJ, Orenstein WA. Measles vaccine efficacy in children previously vaccinated at 12 months of age. Pediatrics 1978; 62: 955–960.
6. Singh R, et al. Immune response to measles, mumps and rubella vaccine at 9, 12 and 15 months of age. Indian Journal of Medical Research 1994; 100: 155–159.
7. Wolfson LJ, et al. Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study. Lancet 2007; 369: 191–200.
8. Wolfson LJ, et al. Estimates of measles case fatality ratios: a comprehensive review of community-based studies. International Journal of Epidemiology 2009; 38: 195–205.
9.WHO/UNICEF. Measles mortality reduction and regional elimination: strategic plan 2001–2005. Geneva: WHO/UNICEF, 2001.
10. Rosenthal SR, Clements CJ. Two dose measles vaccination schedules. Bulletin of the World Health Organization 1993; 71: 421–428.
11. Grais RF, et al. Unacceptably high mortality related to measles epidemics in Niger, Nigeria and Chad. PLoS Medicine 2007; 4: e16.
12. Clark A, Sanderson C. Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data. Lancet 2009; 373: 1543–1549.
13.WHO/UNICEF. Joint Annual Measles Report, 2008.
14. Bauch CT, Szusz E, Garrison LP. Scheduling of measles vaccination in low-income countries: Projections of a dynamic model. Vaccine 2009; 27: 4090–4098.
15. Garly ML, et al. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy. International Journal of Epidemiology 1999; 28: 347–352.
16. Earn DJD, et al. A simple model for complex dynamical transitions in epidemics. Nature 2000; 287: 667–670.
17. Ferrari MJ, et al. The dynamics of measles in sub-Saharan Africa. Nature 2008; 451: 679–684.
18. Klepac P, et al. Stage structured transmission of phocine distemper virus in the Dutch 2002 outbreak. Proceedings of the Royal Society of London, Series B 2009; 276: 2469–2476.
19. Klepac P, Caswell H. The stage-structured epidemic: linking disease and demography with a multi-state matrix model approach. Theoretical Ecology (in press).
20. Bjørnstad ON, Finkenstädt B, Grenfell BT. Endemic and epidemic dynamics of measles: Estimating epidemiological scaling with a time series SIR model. Ecological Monographs 2002; 72: 169–184.
21. Finkenstädt B, Grenfell BT. Time series modelling of childhood diseases: a dynamical systems approach. Journal of the Royal Statistical Society, Series C 2000; 49: 187–205.
22. Grenfell BT, Bjørnstad ON, Finkenstädt BF. Dynamics of measles epidemics. Scaling noise, determinism and predictability with the time series SIR model. Ecological Monographs 2002; 72: 185–202.
23. Glass K, Xia Y, Grenfell BT. Interpreting time-series analyses for continuous-time biological models-measles as a case study. Journal of Theoretical Biology 2003; 223: 19–25.
24. Ferrari MJ, et al. Episodic outbreaks bias estimates of age specific force of infection: a corrected method using measles in Niamey, Niger as an example. Epidemiology and Infection 2010; 138: 108–116.
25. Edmunds WJ, et al. The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies. Epidemiology and Infection 2000; 125: 635–650.
26. Schenzle D. Estimation of the basic reproduction number for infectious diseases from age-stratified serological survey data. IMA Journal of Mathematics Applied in Medicine and Biology 1984; 1: 161–191.
27.WHO. Life tables. World Health Organization, 2008.
28. Altintas DU, et al. The modification in measles vaccination age as a consequence of the earlier decline of transplacentally transferred antimeasles antibodies in Turkish infants. European Journal of Epidemiology 2004; 12: 647–648.
29. Klinge J, et al. Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9–11, 12–14 or 15–17 months of age. Vaccine 2000; 18: 3134–3140.